Evofem is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Evofem Biosciences develops and commercializes hormone-free, woman-controlled contraceptive products, including the FDA-approved Phexxi vaginal gel, an on-demand prescription birth control.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.